We collaborate extensively, both locally, nationally and internationally, and the list will never be completely up to date.

Local collaborators:

Many clinicians locally contribute to our studies, and I will here only mention our main collaborators, Kirsten Sundby Hall, Sigbjørn Smeland, and Bodil Bjerkehagen.

We collaborate with a number of groups within the Centre for research-based Innovation on Cancer Stem cells, for which OM is Assistant Manging Director.

The group of Ragnhild Lothe is important both for a number of sarcoma studies, and for common technology projects, using genomic arrays etc, and lately we collaborate on setting up high throughput "deep" sequencing.

We investigate the properties of mesenchymal stem cells and their applications as model systems as members of the Norwegian Centre for Stem Cell Research (NCS).

National collaborators:

Main national collaborators are the FUGE-funded "Nuclear Program Consortium", Odd S Gabbrielsen, Philippe Collas, and Fahri Saatcioglu. In particular, we have collaborated with Odd's group on myb-proteins, two hybrid analysis, and microarray technology for a number of years.

We collaborate with the groups of Arne Sandvik (NTNU) and Vidar Steen UiB) through our Norwegian Microarray Consortium, but also on several related technology projects.

Several groups collaborate on projects related to microarray technology due to our involvement in the FUGE platform.

International collaborators:

Together with Drs David Thomas (Peter MacCallum Cancer Centre, Melbourne), Robert Maki (Memorial Sloan-Kettering Cancer Centre, New York), and Jordi Barretina (Broad Inst, Harvard, Cambridge, USA) we have intiated a major effort in translational research on liposarcpoma, funded by the Shriver Foundation.

We have a collaboration with Dr Sendurai Mani at the MD Anderson Cancer Centre in Houston on the involvement of HMGA2 in EMT of breast cancer, and Dr Else Munthe had a research visit there in 2010.

We collaborate on several studies on the molecular biology of sarcomas with groups associated with the Scandinavian Sarcoma Group (SSG), such as that of Mef Nilbert, Nils Mandahl and Åke Borg (Lund), Sakari Knuutila (Helsinki), and Olle Larsson (Stockholm).

We are active members of the European network of Excellence on Bone Tumours, EuroBoNeT, in which we have special responsibilities for research on osteosarcoma. As part of the Scandinavian Sarcoma Group, we collaborate with a number of institutions world-wide in the EURAMOS study on chemotherapy in osteosarcoma.